Case study: Dengue

Statement 6 Nov 2024

IFPMA-INTERFARMA-FIFARMA statement on the Rio de Janeiro Declaration of the G20 Health Ministers

The innovative pharmaceutical industry, represented by IFPMA, INTERFARMA and FIFARMA reiterates its commitment to the G20 health priorities, reaffirmed in the Rio de Janeiro Declaration.

The value of prevention for economic growth and the sustainability of healthcare, social care and welfare systems (The European House – Ambrosetti)

Over the last decade, the EU economy has experienced slow growth, and it is not expected to grow substantially in the coming years. Additionally, the ongoing demographic and epidemiological transition is increasing pressure on public finances, particularly healthcare and social expenditure. The current permacrisis – encompassing geopolitical and climate-related challenges – exacerbates these issues and...

Only an urgent shift towards prevention-based healthcare can secure economic stability for EU health systems, experts say

As Governments of EU Member States present their medium-term fiscal structural plans on 20 September, a new report developed by The European House – Ambrosetti, supported by IFPMA and Vaccines Europe, notes that embedding preventative healthcare – in particular immunisation – into EU Member States’ fiscal policies is paramount to ensure the economic sustainability of...